Feedback

Female sex is linked to a stronger association between sTREM2 and CSF p-tau in Alzheimer’s disease

ORCID
0000-0002-2597-1992
Affiliation
Institute for Stroke and Dementia Research (ISD) University Hospital, LMU Munich Munich Germany
Biel, Davina;
ORCID
0000-0002-2993-569X
Affiliation
Barcelonaβeta Brain Research Center (BBRC) Pasqual Maragall Foundation Barcelona Spain
Suárez-Calvet, Marc;
Affiliation
Institute for Stroke and Dementia Research (ISD) University Hospital, LMU Munich Munich Germany
Dewenter, Anna;
ORCID
0000-0002-8438-3760
Affiliation
Institute for Stroke and Dementia Research (ISD) University Hospital, LMU Munich Munich Germany
Steward, Anna;
ORCID
0000-0003-3423-457X
Affiliation
Institute for Stroke and Dementia Research (ISD) University Hospital, LMU Munich Munich Germany
Roemer, Sebastian N;
ORCID
0000-0001-7116-9741
Affiliation
Institute for Stroke and Dementia Research (ISD) University Hospital, LMU Munich Munich Germany
Dehsarvi, Amir;
Affiliation
Institute for Stroke and Dementia Research (ISD) University Hospital, LMU Munich Munich Germany
Zhu, Zeyu;
Affiliation
Institute for Stroke and Dementia Research (ISD) University Hospital, LMU Munich Munich Germany
Pescoller, Julia;
Affiliation
Institute for Stroke and Dementia Research (ISD) University Hospital, LMU Munich Munich Germany
Frontzkowski, Lukas;
Affiliation
Department of Nuclear Medicine University Hospital, LMU Munich Munich Germany
Kreuzer, Annika;
ORCID
0000-0002-4869-1627
Affiliation
German Center for Neurodegenerative Diseases (DZNE) Munich Germany
Haass, Christian;
ORCID
0000-0001-7800-1781
Affiliation
University of Gothenburg, The Sahlgrenska Academy Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry Mölndal and Gothenburg Sweden
Schöll, Michael;
Affiliation
Department of Nuclear Medicine University Hospital, LMU Munich Munich Germany
Brendel, Matthias;
ORCID
0000-0001-9736-2283
Affiliation
Institute for Stroke and Dementia Research (ISD) University Hospital, LMU Munich Munich Germany
Franzmeier, Nicolai

Abstract In Alzheimer’s disease (AD), Aβ triggers p-tau secretion, which drives tau aggregation. Therefore, it is critical to characterize modulators of Aβ-related p-tau increases which may alter AD trajectories. Here, we assessed whether factors known to alter tau levels in AD modulate the association between fibrillar Aβ and secreted p-tau 181 determined in the cerebrospinal fluid (CSF). To assess potentially modulating effects of female sex, younger age, and ApoE4, we included 322 ADNI participants with cross-sectional/longitudinal p-tau 181 . To determine effects of microglial activation on p-tau 181 , we included 454 subjects with cross-sectional CSF sTREM2. Running ANCOVAs for nominal and linear regressions for metric variables, we found that women had higher Aβ-related p-tau 181 levels. Higher sTREM2 was associated with elevated p-tau 181 , with stronger associations in women. Similarly, ApoE4 was related to higher p-tau 181 levels and faster p-tau 181 increases, with stronger effects in female ApoE4 carriers. Our results show that sex alone modulates the Aβ to p-tau axis, where women show higher Aβ-dependent p-tau secretion, potentially driven by elevated sTREM2-related microglial activation and stronger effects of ApoE4 carriership in women.

Synopsis This study examined whether sex, age, microglial activation or ApoE4 modulates the Aβ to p-tau axis, a critical event in the amyloid cascade that triggers the progression of Alzheimer’s disease (AD) from amyloidosis towards tauopathy. Only sex but not age, sTREM2-related microglial activation or ApoE4 modulated the Aβ to p-tau axis. Higher sTREM2-related microglial activation and ApoE4 positivity were linked to elevated p-tau levels, with stronger associations in women than in men. Female sex is associated with a stronger Aβ-dependent p-tau secretion, potentially driven by elevated sTREM2-related microglial activation.

This study examined whether sex, age, microglial activation or ApoE4 modulates the Aβ to p-tau axis, a critical event in the amyloid cascade that triggers the progression of Alzheimer’s disease (AD) from amyloidosis towards tauopathy.

Cite

Citation style:
Could not load citation form.

Access Statistic

Total:
Downloads:
Abtractviews:
Last 12 Month:
Downloads:
Abtractviews:

Rights

License Holder: © The Author(s) 2025

Use and reproduction: